Back to results
US 2011/0212186 A1Published application
Composition for treating autoimmune disorders
OwnerJohannes Gislason, Jon M. Einarsson +1inventors
InventorsJohannes Gislason, Jon M. Einarsson, Chuen How Ng
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition, use and a method for reducing inflammation and promoting tissue repair or tissue regeneration through a synergistic effect of T-ChOS and Glucosamine and/or N-acetyl glucosamine systemically or locally administered in humans and other mammals in need thereof.
Claims13
A composition comprising:
- therapeutically active chitooligomers of N-acetyl glucosamine (A) and glucosamine (D), wherein the chitooligomers comprise hetero-chitooligomers which fulfill the following criteria:
- said oligomers having a chain length in the range of 5-20 monomer residues
- each oligomer chain can have two N-acetyl glucosamine residues (AA) on either or both ends of the oligomer chain,
- the remaining internal part of the oligomer having at least enough amount of D residues to avoid that the sequence of said internal chain comprises an N-acetyl glucosamine residue (A) adjacent to another N-acetyl glucosamine residue (such as AA),
- in combination with glucosamine and/or N-acetyl glucosamine.
2 more elements
8-9. (canceled)
14-16. (canceled)
Dependencies are inferred from the claim text.